Grants and Contributions:
Title:
Support for Pharma SMEs in the Prairies
Agreement Number:
1020113
Agreement Value:
$71,880.00
Agreement Date:
Jul 1, 2024 - Mar 31, 2026
Description:
As a pilot project, the general objective of the proposed project is to identify and assist SME firms engaged in pharmaceutical development and manufacturing who will be undergoing a regulatory body (FDA, HC, EMA, etc) audit. Identification of firms, creation of awareness, and building of networks in quality assurance and regulatory compliance.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Markham, Ontario, CA L3R 5B4
Reference Number:
172-2024-2025-Q2-1020113
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
124665852
Recipient Type:
Not-for-profit organization or charity
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days. The total amended value is 4,500 dollars.
Amendment Date
Feb 12, 2026
Recipient's Legal Name:
National Pharmaceutical Sciences Group Inc.
Federal Riding Name:
Markham--Unionville
Federal Riding Number:
35056
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Organizations is to support Organizations in providing innovation assistance services to small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
3254
Amendments: